Pengcheng Kang

1.3k total citations
36 papers, 764 citations indexed

About

Pengcheng Kang is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Pengcheng Kang has authored 36 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cancer Research, 23 papers in Surgery and 22 papers in Molecular Biology. Recurrent topics in Pengcheng Kang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Cancer-related molecular mechanisms research (17 papers) and MicroRNA in disease regulation (10 papers). Pengcheng Kang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Cancer-related molecular mechanisms research (17 papers) and MicroRNA in disease regulation (10 papers). Pengcheng Kang collaborates with scholars based in China, Hong Kong and United States. Pengcheng Kang's co-authors include Yunfu Cui, Xiangyu Zhong, Xingming Jiang, Yi Xu, Kaiming Leng, Zhenglong Li, Zhidong Wang, Chunlong Li, Wei Qin and Ming Wan and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pengcheng Kang

34 papers receiving 761 citations

Peers

Pengcheng Kang
Yue Yao China
Yongqian Shu China
Renhua Guo China
Xianzi Yang China
Xuehai Xie China
HE Xiu-sheng China
Xiaxing Deng China
Chengkun Qin China
Yue Yao China
Pengcheng Kang
Citations per year, relative to Pengcheng Kang Pengcheng Kang (= 1×) peers Yue Yao

Countries citing papers authored by Pengcheng Kang

Since Specialization
Citations

This map shows the geographic impact of Pengcheng Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Kang more than expected).

Fields of papers citing papers by Pengcheng Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengcheng Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Kang. The network helps show where Pengcheng Kang may publish in the future.

Co-authorship network of co-authors of Pengcheng Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Pengcheng Kang. A scholar is included among the top collaborators of Pengcheng Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengcheng Kang. Pengcheng Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Xinlei, et al.. (2025). A Novel 167‐Amino Acid Protein Encoded by CircPCSK6 Inhibits Intrahepatic Cholangiocarcinoma Progression via IKBα Ubiquitination. Advanced Science. 12(10). e2409173–e2409173. 4 indexed citations
2.
Li, Tengfei, Xun Li, Pengcheng Kang, & Jinmin Zhao. (2025). Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma. Translational Oncology. 53. 102283–102283.
3.
4.
Kang, Pengcheng, et al.. (2023). Silenced LASP1 interacts with DNMT1 to promote TJP2 expression and attenuate articular cartilage injury in mice by suppressing TJP2 methylation. The Kaohsiung Journal of Medical Sciences. 39(11). 1096–1105. 2 indexed citations
5.
Wang, Jiangang, Xinlei Zou, Jianjun Gao, et al.. (2023). Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies. Frontiers in Medicine. 10. 1120621–1120621. 18 indexed citations
6.
Liu, Yang, Wenxin Yin, Xiaoxia Li, et al.. (2023). Comparative analysis of tumor biology and prognosis in mucinous and signet-ring cell colon cancers versus classical adenocarcinoma. Frontiers in Physiology. 14. 1199211–1199211.
7.
Li, Jinglin, Xingming Jiang, Yi Xu, et al.. (2022). YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. International Journal of Biological Sciences. 18(11). 4301–4315. 16 indexed citations
8.
Xia, Haoming, Ziyue Huang, Shuqiang Liu, et al.. (2021). Exosomal Non-Coding RNAs: Regulatory and Therapeutic Target of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 653846–653846. 3 indexed citations
9.
Huang, Ziyue, Haoming Xia, Shuqiang Liu, et al.. (2021). The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 714665–714665. 10 indexed citations
10.
11.
Ji, Daolin, Peng Huang, Yue Yao, et al.. (2020). <p>Huaier Restrains Cholangiocarcinoma Progression in vitro and in vivo Through Modulating lncRNA TP73-AS1 and Inducing Oxidative Stress</p>. OncoTargets and Therapy. Volume 13. 7819–7837. 16 indexed citations
12.
Leng, Kaiming, Yi Xu, Pengcheng Kang, et al.. (2019). Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway. Cell Death and Disease. 10(4). 262–262. 31 indexed citations
13.
Qin, Wei, Pengcheng Kang, Yi Xu, et al.. (2018). Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma. Scientific Reports. 8(1). 12176–12176. 41 indexed citations
14.
Xu, Yi, Yue Yao, Xingming Jiang, et al.. (2018). SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 81–81. 123 indexed citations
15.
Zhang, Fumin, Ming Wan, Yi Xu, et al.. (2017). Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt/β-catenin-signaling pathway. Biomedicine & Pharmacotherapy. 94. 55–62. 63 indexed citations
16.
Wan, Ming, Fumin Zhang, Zhenglong Li, et al.. (2016). Identifying survival-associated ceRNA clusters in cholangiocarcinoma. Oncology Reports. 36(3). 1542–1550. 11 indexed citations
17.
Liu, Ning, Fan Jiang, Tianlin He, et al.. (2015). The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma Cells. Scientific Reports. 5(1). 16566–16566. 24 indexed citations
18.
Cao, Liping, et al.. (2015). Interleukin-6 induces epithelial-mesenchymal transition in human intrahepatic biliary epithelial cells. Molecular Medicine Reports. 13(2). 1563–1569. 15 indexed citations
19.
Kang, Pengcheng, Ming Wan, Peng Huang, et al.. (2014). The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma. PLoS ONE. 9(3). e90308–e90308. 24 indexed citations
20.
Guichard, Sylvie M., et al.. (2007). Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model. Cancer Chemotherapy and Pharmacology. 60(5). 651–660. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yue Yao Breakdown of academic impact, for papers by Yongqian Shu Breakdown of academic impact, for papers by Renhua Guo Breakdown of academic impact, for papers by Xianzi Yang Breakdown of academic impact, for papers by Xuehai Xie Breakdown of academic impact, for papers by HE Xiu-sheng Breakdown of academic impact, for papers by Xiaxing Deng Breakdown of academic impact, for papers by Chengkun Qin
Rankless by CCL
2026